Kohlberg Kravis Roberts & Co. L.P.
Position in BBIO — BridgeBio Pharma, Inc.
CIK 1399770
NEW YORK, NY
Position in BBIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$984,759,706
-$29,571,965 QoQ
Shares Held
13,260,971
0.0% QoQ
Ownership
6.77%
of shares outstanding
% of Portfolio
19.31%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Kohlberg Kravis Roberts & Co. L.P. holds $989,890,674 across 2 Biotechnology names. BBIO ranks #1 (99.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
This page
|
13,260,971 | $984,759,706 | |
| 2 | CHRS |
Coherus Oncology, Inc.
|
3,036,076 | $5,130,968 |
All Filings in BBIO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $984,759,706 | 13,260,971 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,014,331,671 | 13,260,971 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $688,774,833 | 13,260,971 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $572,608,727 | 13,260,971 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $665,851,767 | 19,260,971 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $693,161,044 | 25,260,971 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $643,144,321 | 25,260,971 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $786,774,395 | 31,060,971 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $960,405,223 | 31,060,971 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $1,253,931,399 | 31,060,971 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $819,077,805 | 31,060,971 | Shares | Other | 2024-01-22 | |
| 2023-06-30 | $534,248,701 | 31,060,971 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $514,990,899 | 31,060,971 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $236,684,599 | 31,060,971 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $308,746,051 | 31,060,971 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $282,033,616 | 31,060,971 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $315,268,855 | 31,060,971 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $518,096,996 | 31,060,971 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $1,455,827,710 | 31,060,971 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $1,893,476,792 | 31,060,971 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $1,913,355,813 | 31,060,971 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $2,454,075,147 | 34,510,971 | Shares | Other | 2021-02-16 | |
| 2020-09-30 | $1,294,851,631 | 34,510,971 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $1,125,402,764 | 34,510,971 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $1,070,119,169 | 36,900,661 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||